Analysen von Matthew Weston
| 29.04.25 | AstraZeneca Buy | UBS AG | |
| 25.04.25 | Merck Buy | UBS AG | |
| 25.04.25 | Roche Buy | UBS AG | |
| 24.04.25 | Roche Buy | UBS AG | |
| 14.04.25 | Roche Buy | UBS AG | |
| 10.04.25 | AstraZeneca Buy | UBS AG | |
| 07.04.25 | Roche Buy | UBS AG | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
|
Werbung
|
|||
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 12.03.25 | Roche Buy | UBS AG | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 12.03.25 | Merck Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 07.03.25 | Merck Buy | UBS AG | |
| 06.03.25 | Merck Buy | UBS AG | |
| 27.02.25 | Merck Buy | UBS AG | |
| 21.02.25 | Roche Buy | UBS AG | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 27.01.25 | Novartis Buy | UBS AG | |
| 21.11.24 | Novartis Buy | UBS AG | |
| 15.11.24 | Merck Buy | UBS AG | |
| 14.11.24 | Novartis Buy | UBS AG | |
| 14.11.24 | Merck Buy | UBS AG | |
| 30.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Buy | UBS AG | |
| 23.10.24 | Merck Buy | UBS AG | |
| 17.10.24 | Merck Buy | UBS AG | |
| 13.09.24 | Merck Buy | UBS AG | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 06.08.24 | Merck Buy | UBS AG | |
| 01.08.24 | Merck Buy | UBS AG | |
| 29.07.24 | Merck Buy | UBS AG | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 10.07.24 | Merck Buy | UBS AG | |
| 25.06.24 | Merck Buy | UBS AG | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 23.05.24 | Merck Buy | UBS AG | |
| 15.05.24 | Merck Buy | UBS AG | |
| 08.05.24 | Merck Buy | UBS AG | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 26.03.24 | Merck Buy | UBS AG | |
| 07.03.24 | Merck Buy | UBS AG | |